ArticleVaccines2022

Efficacy and Safety of Heterologous Booster Vaccination after Ad5-nCoV (CanSino Biologics) Vaccine: A Preliminary Descriptive Study.

José Francisco Muñoz-Valle et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.